Ciltacabtagene Autoleucel (Cilta-cel) Vs Standard of Care (SoC) in Patients with Lenalidomide (Len)-Refractory Multiple Myeloma (MM) after 1-3 Lines of Therapy: Minimal Residual Di... by Popat, Rakesh, Oriol, Albert, Cavo, Michele, Karlin, Lionel, Avivi Mazza, Irit, Roeloffzen, Wilfried, Kim, Seok Jin, Lipe, Brea, Bar, Noffar, Horvath, Noemi, Spencer, Andrew, Min, Chang-Ki, Chen, Diana, Li, Quanlin, Li, Katherine, Slaughter, Ana, Lonardi, Carolina, Benachour, Nina, Ghosh, Arnab, Vogel, Martin, Lendvai, Nikoletta, Lengil, Tamar, Patel, Nitin, Costa Filho, Octavio, Florendo, Erika, Lin, Yi

Get full text

Comparative Efficacy of Ciltacabtagene Autoleucel Versus Isatuximab, Carfilzomib and Dexamethasone in the Treatment of Patients with Lenalidomide-Refractory Multiple Myeloma with 1... by Mina, Roberto, Corradini, Paolo, Cavo, Michele, San-Miguel, Jesús F., Shune, Leyla O., Khan, Abdullah Mohammad, Sidana, Surbhi, Leleu, Xavier, Manier, Salomon, Lipe, Brea, Weisel, Katja C., van Sanden, Suzy, Diels, Joris, Mendes, João, Lee, Seina, Van Hoorenbeeck, Sandra, Pons, Adrián, Slaughter, Ana, Benachour, Nina, Lonardi, Carolina, Ghosh, Arnab, Patel, Nitin, Florendo, Erika, Martínez-Lopez, Joaquín

Get full text

Long-Term Benefits in Patient-Reported Outcomes and Time to Next Anti-Myeloma Therapy of Ciltacabtagene Autoleucel (Cilta-cel) Versus Standard of Care for Patients with Lenalidomid... by Bar, Noffar, Mina, Roberto, Mylin, Anne K., Yokoyama, Hisayuki, Magen, Hila, Alsdorf, Winfried, Minnema, Monique C., Shune, Leyla O., Isufi, Iris, Harrison, Simon J, Shah, Urvi A., De Champlain, André, Gries, Katharine S., Chen, Diana, Li, Quanlin, Yeh, Tzu-Min, Slaughter, Ana, Lonardi, Carolina, Benachour, Nina, Ghosh, Arnab, Deraedt, William, Vogel, Martin, Lendvai, Nikoletta, Patel, Nitin, Costa Filho, Octavio, Florendo, Erika, Karlin, Lionel, Weisel, Katja C.

Get full text

P-057 Comparative Efficacy of Cilta-Cel vs Approved Comparator Treatments for Patients With Relapsed/Refractory Multiple Myeloma With 1–3 Prior Lines of Therapy: A Network Meta-Ana... by Mina, Roberto, Khan, Abdullah, McClune, Brian, Bar, Noffar, Caers, Jo, Larsen, Jeremy, Mendes, João, Lee, Seina, Benachour, Nina, Chen, Diana, Zhao, Man, Lonardi, Carolina, Slaughter, Ana, Lengil, Tamar, Burnett, Heather, Cichewicz, Allie, Neupane, Binod, Filho, Octavio Costa, Dytfeld, Dominik, Sidana, Surbhi

Get full text

Effectiveness of Bridging Therapy Corresponds to Improved Outcomes After Receiving CAR-T Therapy: Phase 3 CARTITUDE-4 Study of Patients With Relapsed, Lenalidomide-Refractory Multi... by Lin, Yi, Leleu, Xavier, Gatt, Moshe, Karlin, Lionel, Spencer, Andrew, Iida, Shinsuke, Ishida, Tadao, Anguille, Sébastien, Min, Chang-Ki, Jin Kim, Seok, Slaughter, Ana, Lonardi, Carolina, Benachour, Nina, Vogel, Martin, Lendvai, Nikoletta, Plaks, Vicki, Li, Katherine, Chen, Diana, Li, Quanlin, Lengil, Tamar, Koneru, Mythili, Patel, Nitin, Costa Filho, Octavio, Harrison, Simon J., San-Miguel, Jesús, Einsele, Hermann

Get full text

Ciltacabtagene Autoleucel vs Standard of Care in Lenalidomide-Refractory Multiple Myeloma: Phase 3 CARTITUDE-4 Subgroup Analysis by Cytogenetic Risk by Mina, Roberto, Dhakal, Binod, San-Miguel, Jesus, Kwon, Mi, Purtill, Duncan, Magen, Hila, Dutka, Magdalena, Delforge, Michel, Vij, Ravi, Wichert, Stina, Yoon, Sung-Soo, Minnema, Monique C., Lendvai, Nikoletta, Lonardi, Carolina, Slaughter, Ana, Vogel, Martin, Li, Katherine, Chen, Diana, Zhao, Man, Yeh, Tzu-min, Benachour, Nina, Lengil, Tamar, Koneru, Mythili, Patel, Nitin, Florendo, Erika, Costa Filho, Octavio, Einsele, Hermann, Manier, Salomon, Martinez-Lopez, Joaquin

Get full text

P-005 Effectiveness of Bridging Therapy Corresponds to Improved Outcomes After Receiving CAR-T Therapy: Phase 3 CARTITUDE-4 Study of Patients With Relapsed, Lenalidomide-Refractory... by Anguille, Sébastien, Leleu, Xavier, Gatt, Moshe, Karlin, Lionel, Spencer, Andrew, Iida, Shinsuke, Ishida, Tadao, Lin, Yi, Min, Chang-Ki, Kim, Seok Jin, Slaughter, Ana, Lonardi, Carolina, Benachour, Nina, Vogel, Martin, Plaks, Vicki, Li, Katherine, Chen, Diana, Li, Quanlin, Lengil, Tamar, Koneru, Mythili, Patel, Nitin, Filho, Octavio Costa, Harrison, Simon, San-Miguel, Jesús, Einsele, Hermann

Get full text

OA-65 Overall Survival (OS) With Ciltacabtagene Autoleucel (Cilta-cel) Versus Standard of Care (SoC) in Lenalidomide (Len)-Refractory Multiple Myeloma (MM): Phase 3 CARTITUDE-4 Stu... by Mateos, María-Victoria, San-Miguel, Jesús, Dhakal, Binod, Touzeau, Cyrille, Leleu, Xavier, van de Donk, Niels W.C.J., Sidana, Surbhi, Oriol, Albert, Cohen, Yaël C., Harrison, Simon J., Einsele, Hermann, Corradini, Paolo, Chen, Diana, Li, Quanlin, Li, Katherine, Slaughter, Ana, Lonardi, Carolina, Benachour, Nina, Vogel, Martin, Lendvai, Nikoletta, Koneru, Mythili, Patel, Nitin, Florendo, Erika, Ho, P. Joy, Popat, Rakesh

Get full text

MM-522 Effectiveness of Bridging Therapy Corresponds to Improved Outcomes After Receiving CAR-T Therapy: Phase 3 CARTITUDE-4 Study of Patients With Relapsed, Lenalidomide-Refractor... by Lin, Yi, Leleu, Xavier, Gatt, Moshe, Karlin, Lionel, Spencer, Andrew, Iida, Shinsuke, Ishida, Tadao, Anguille, Sébastien, Ki, Chang-Ki, Jin Kim, Seok, Slaughter, Ana, Lonardi, Carolina, Benachour, Nina, Vogel, Martin, Lendvai, Nikoletta, Plaks, Vicki, Li, Katherine, Chen, Diana, Li, Quanlin, Lengil, Tamar, Koneru, Mythili, Patel, Nitin, Costa Filho, Octavio, Harrison, Simon J., San-Miguel, Jesús, Einsele, Hermann

Get full text

MM-567 Ciltacabtagene Autoleucel vs Standard of Care in Lenalidomide-Refractory Multiple Myeloma: Phase 3 CARTITUDE-4 Subgroup Analysis by Cytogenetic Risk by Mina, Roberto, Dhakal, Binod, San-Miguel, Jesus, Kwon, Mi, Purtill, Duncan, Magen, Hila, Dutka, Magdalena, Delforge, Michel, Vij, Ravi, Wichert, Stina, Yoon, Sung-Soo, Minnema, Monique C., Lendvai, Nikoletta, Lonardi, Carolina, Slaughter, Ana, Vogel, Martin, Li, Katherine, Chen, Diana, Zhao, Man, Yeh, Tzu-min, Benachour, Nina, Lengil, Tamar, Koneru, Mythili, Patel, Nitin, Florendo, Erika, Costa Filho, Octavio, Einsele, Hermann, Manier, Salomon, Martinez-Lopez, Joaquin

Get full text